Latest news
RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias - The Manila TimesThe Manila Times · Sat, 08 Aug 2026 08:04:32 GMTHopstem’s iPSC-Derived hNPC01 Cell Therapy Gains FDA Clearance to Target Three Major Brain Injury Indications - BioInformantBioInformant · Wed, 05 Aug 2026 21:57:41 GMTSatellite Bio Wins FDA IND Clearance for SB-101, Marking Transition to Clinical-Stage Company - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 16:02:37 GMTFDA clearance lets BriaCell test personalized prostate immunotherapy - Stock TitanStock Titan · Wed, 05 Aug 2026 11:30:00 GMTInsilico Medicine secures China NMPA IND clearance for AI-designed NLRP3 inhibitor ISM8969/HT-001 in Parkinson's - DealroomDealroom · Wed, 05 Aug 2026 07:13:43 GMTSatellite Bio Announces FDA Clearance of IND Application for SB-101 for the Treatment of Urea Cycle Disorders (UCDs) Marking its Transition to a Clinical-Stage Biotechnology Company - BioSpaceBioSpace · Wed, 05 Aug 2026 03:09:09 GMTFDA Clears IND for RAG-1C saRNA candidate targeting proliferative vitreoretinopathy - Ophthalmology Times EuropeOphthalmology Times Europe · Mon, 03 Aug 2026 19:02:58 GMTRactigen Therapeutics Announces U.S. FDA IND Clearance for First-in-Class saRNA Candidate RAG-1C to Treat Proliferative Vitreoretinopathy - The Manila TimesThe Manila Times · Fri, 31 Jul 2026 11:26:59 GMT